A phase II dose-ranging study of mirabegron in patients with overactive bladder

被引：0
|
作者：
Christopher R. Chapple
Vladimir Dvorak
Pjotr Radziszewski
Philip Van Kerrebroeck
Jean Jacques Wyndaele
Brigitte Bosman
Peter Boerrigter
Ted Drogendijk
Arwin Ridder
Ingrid Van Der Putten-Slob
Osamu Yamaguchi
机构：
[1] Sheffield Teaching Hospitals,Department of Urology, Royal Hallamshire Hospital
[2] Centrum ambulantní gynekologie a primární péce,Department of Urology
[3] Medical University Warsaw,Department Urology
[4] Maastricht University Medical Center,Department of Urology
[5] Antwerp University and Antwerp University Hospital,Division of Bioengineering and LUTD Research, School of Engineering
[6] Astellas Pharma Europe BV,undefined
[7] Nihon University,undefined
来源：
International Urogynecology Journal | 2013年 / 24卷
关键词：
β; -adrenoceptor agonist; Mirabegron; Overactive; Urinary bladder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1447 / 1458
页数：11
相关论文
共 50 条
  • [41] Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)
    Tomas L. Griebling
    Noll L. Campbell
    Jeffrey Mangel
    David Staskin
    Sender Herschorn
    Dina Elsouda
    Carol R. Schermer
    BMC Geriatrics, 20
  • [42] Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)
    Griebling, Tomas L.
    Campbell, Noll L.
    Mangel, Jeffrey
    Staskin, David
    Herschorn, Sender
    Elsouda, Dina
    Schermer, Carol R.
    BMC GERIATRICS, 2020, 20 (01)
  • [43] Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies
    Tubaro, Andrea
    Batista, Jose E.
    Nitti, Victor W.
    Herschorn, Sender
    Chapple, Christopher R.
    Blauwet, Mary Beth
    Siddiqui, Emad
    Huang, Moses
    Oelke, Matthias
    THERAPEUTIC ADVANCES IN UROLOGY, 2017, 9 (06) : 137 - 154
  • [44] Efficacy and persistence of low-dose mirabegron (25 mg) in patients with overactive bladder: analysis in a real-world urological practice
    Shen, Yuan Chi
    Wang, Hung Jen
    Chuang, Yao Chi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (07) : 1219 - 1226
  • [45] Efficacy and persistence of low-dose mirabegron (25 mg) in patients with overactive bladder: analysis in a real-world urological practice
    Yuan Chi Shen
    Hung Jen Wang
    Yao Chi Chuang
    International Urology and Nephrology, 2018, 50 : 1219 - 1226
  • [46] Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome
    White, William B.
    Siddiqui, Emad
    Tat, Tri
    Franks, Billy
    Schermer, Carol R.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2018, 12 (11) : 768 - 778
  • [47] Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study
    Liang, Ping
    Tang, Qing-lai
    Lin, Tao
    Tang, Zheng-kun
    Liu, Fa-de
    Zhou, Xing-zhu
    Tao, Rong-zhen
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [48] Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice
    Chapple, Christopher R.
    Nazir, Jameel
    Hakimi, Zalmai
    Bowditch, Sally
    Fatoye, Francis
    Guelfucci, Florent
    Khemiri, Amine
    Siddiqui, Emad
    Wagg, Adrian
    EUROPEAN UROLOGY, 2017, 72 (03) : 389 - 399
  • [49] Safety and therapeutic efficacy of mirabegron 25 mg in older patients with overactive bladder and multiple comorbidities
    Lee, Yu Khun
    Kuo, Hann-Chorng
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (09) : 1330 - 1333
  • [50] Comparison of mirabegron and imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT study)
    Otsuka, Atsushi
    Kageyama, Shinji
    Suzuki, Takahisa
    Matsumoto, Rikiya
    Nagae, Hiroshi
    Kitagawa, Motoaki
    Furuse, Hiroshi
    Ozono, Seiichiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (12) : 1016 - 1023
12345